Augmedix, Inc. (AUGX) financial statements (2022 and earlier)

Company profile

Business Address 111 SUTTER STREET, SUITE 1300
SAN FRANCISC, CA 94104
State of Incorp. DE
Fiscal Year End December 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments41,25520,7620
Cash and cash equivalents41,25520,7620
Restricted cash and investments1252,211 
Receivables7,1782,693 
Other undisclosed current assets1,8681,104 
Total current assets:50,42626,7690
Noncurrent Assets
Property, plant and equipment982992 
Other undisclosed noncurrent assets275173 
Total noncurrent assets:1,2571,166 
TOTAL ASSETS:51,68327,9350
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,6243,3683
Accounts payable1,365259 
Accrued liabilities4,2593,1093
Deferred revenue6,2385,439 
Debt1,5006,613 
Due to related parties  66
Customer refund liability6321,053 
Total current liabilities:13,99416,47369
Noncurrent Liabilities
Long-term debt and lease obligation 8,338 
Long-term debt, excluding current maturities 8,338 
Liabilities, other than long-term debt273  
Deferred rent credit273  
Other undisclosed noncurrent liabilities13,732  
Total noncurrent liabilities:14,0058,338 
Total liabilities:27,99924,81169
Stockholders' equity
Stockholders' equity attributable to parent23,6843,124(68)
Common stock431
Additional paid in capital125,47987,051 
Accumulated other comprehensive loss(70)(52) 
Accumulated deficit(101,729)(83,878)(69)
Total stockholders' equity:23,6843,124(68)
TOTAL LIABILITIES AND EQUITY:51,68327,9350

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Revenues22,16516,483 
Cost of revenue(12,158)(9,690) 
Cost of goods and services sold (3,400) 
Gross profit:10,0076,794 
Operating expenses(27,945)(20,486)(31)
Operating loss:(17,938)(13,692)(31)
Nonoperating income (expense)87(1,911) 
Investment income, nonoperating1511 
Foreign currency transaction gain, before tax2,180  
Other nonoperating income (expense)390(469) 
Interest and debt expense(679)(1,453)(3)
Loss from continuing operations before income taxes:(18,530)(17,057)(34)
Income tax expense(977)  
Loss before gain (loss) on sale of properties:(19,507)(17,057)(34)
Other undisclosed net income1,6561,453 
Net loss:(17,851)(15,604)(34)
Net loss attributable to noncontrolling interest(17,900)(15,600) 
Other undisclosed net income attributable to parent17,90015,600 
Net loss available to common stockholders, diluted:(17,851)(15,604)(34)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Net loss:(17,851)(15,604)(34)
Other undisclosed comprehensive loss(18)(11) 
Comprehensive loss:(17,869)(15,614)(34)
Comprehensive loss, net of tax, attributable to noncontrolling interest(17,900)(15,600) 
Comprehensive loss, net of tax, attributable to parent:(35,769)(31,214)(34)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: